نتائج البحث 91-100 من 8113 لعملية البحث عن Anal%2Bcancer
... (2) Cohort 2 focuses on primary or secondary ... Cancer” (Principal Investigator Dr. Gendler) ... colorectal cancer, (6) advanced, unresectable ovarian ...
To achieve this shorter course, proton therapy is used. This study aims to determine cancer control at 2 years after study registration. It also aims to ...
... rectal cancer that has spread to other places in the body (advanced). ... 2 (HER2). HER2 is found on some cancer cells ... When pertuzumab or trastuzumab attach to ...
... cancer. Eligible patients presenting with apparent uterine confined grade 1, 2, or 3 endometrioid endometrial cancer will undergo standard-of-care primary ...
Cohort 2 includes (1) muCALR+ primary MF, and (2) muCALR+ secondary MF. ... Patients in cohorts 1.11 and 1.12 (currently lacking detectable cancer) will undergo ...
A Study of Selpercatinib Following Definitive Locoregional Treatment in Participants with Non-small Cell Lung Cancer ... (2) Cohort 2 focuses on primary or ...
Also eligible are (11) up to 6 donors with triple negative breast cancer and (12) up to 6 donors with colorectal cancer who have no clinical evidence of ...
A Study to Evaluate Exemestane in Post-Menopausal Women with Non-Small Cell Lung Cancer (NSCLC) ... 2B (Dose Expansion) with Cohort D1 (monotherapy SAR444881).
Patients in the GDC-0199+R arm will continue GDC-0199 treatment until disease progression or 2 years since treatment start, whichever comes first. Anticipated ...
لا تُقدم Mayo Clinic الدعم للشركات أو المنتجات المُعلَّن عنها هنا. لكن تدعم العائدات الإعلانية رسالتنا غير الربحية.
تحقق من هذه الكتب الأكثر مبيعًا والعروض الخاصة على الكتب والنشرات الإخبارية من Mayo Clinic Press.
تساهم التبرّعات، وهي قابلة للخصم الضريبي، في دعم آخر التطورات في الأبحاث وطرق الرعاية لإحداث نقلة نوعية في الطب.